Canada markets open in 8 hours 2 minutes

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
8.35-0.15 (-1.76%)
At close: 1:02PM EST
Full screen
Previous Close8.50
Open8.36
Bid8.35 x 0
Ask8.50 x 0
Day's Range8.35 - 8.40
52 Week Range6.76 - 9.59
Volume2,300
Avg. Volume4,709
Market Cap105.167M
Beta (5Y Monthly)0.97
PE Ratio (TTM)21.19
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    BioSyent Releases Q3 and YTD 2021 Financial Results

    MISSISSAUGA, Ontario, Nov. 18, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2021. Key highlights include: Third quarter (Q3) 2021 Net Revenues of $6,690,419 increased by 16% versus Q3 2020Year-to-date (YTD) 2021 Net Revenues of $21,399,562 increased by 29% versus YTD 2020Canadian Pharmaceutical Net Revenues in Q3 2021 of $6,409,809 increased by 17% versus Q3 2020YTD 2021 Canadian Pharma

  • GlobeNewswire

    BioSyent Schedules Q3 and YTD 2021 Earnings Release for November 18, 2021

    MISSISSAUGA, Ontario, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2021 on Thursday, November 18, 2021 at 5:00pm ET. A presentation on the Company’s third quarter and year-to-date 2021 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchan

  • GlobeNewswire

    BioSyent Announces Launch of New FeraMAX® Pd Powder 15

    FeraMAX Pd Powder 15 Package FeraMAX Pd Powder 15 Package MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the launch of FeraMAX® Pd Powder 15 by its subsidiary, BioSyent Pharma Inc., in Canada. FeraMAX® Pd Powder 15 is the second product incorporating Polydextrose-Iron Complex (PDIC), a patented oral iron supplement delivery system. In November 2020, BioSyent Pharma Inc. launched FeraMAX® Pd Therapeutic 150